Clinical Trial Update: Rezafungin Prophylaxis in Liver Transplant [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on rezafungin as prophylaxis to prevent fungal infections in liver transplant recipients; currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungal Infections
• Liver Transplantation

Drugs mentioned

• Rezafungin (rezafungin)

Snippet

Sponsor: Fernanda P Silveira, MD, MS | Conditions: Liver Transplant Infection, Fungal Infection | Phase 3 | Status: ENROLLING_BY_INVITATION